🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,136 results for “First Tracks Biotherapeutics” Clear

  1. Visilizumab

    First Tracks Biotherapeutics

    Immunotherapy

    phase 3 small molecule active

    1 trial

  2. Ypeginterferon alfa-2b

    First Tracks Biotherapeutics

    Chronic Hepatitis B

    phase 3 small molecule completed

    3 trials

  3. decitabine

    First Tracks Biotherapeutics

    Acute Myelocytic Leukemia

    phase 3 small molecule active

    1 trial

  4. decitabine

    First Tracks Biotherapeutics

    Poor Graft Function

    phase 3 small molecule active

    1 trial

  5. didroxyprogesterone

    First Tracks Biotherapeutics

    Pregnancy Rate

    phase 3 small molecule active

    1 trial

  6. different degrees of adjustment of the injection interval

    First Tracks Biotherapeutics

    Exudative Age-Related Macular Degeneration

    phase 3 small molecule active

    1 trial

  7. donor lymphocyte infusion

    First Tracks Biotherapeutics

    Minimal Residual Disease

    phase 3 mab completed

    1 trial

  8. esophagectomy

    First Tracks Biotherapeutics

    Esophageal Cancer

    phase 3 other active

    1 trial

  9. metformin

    First Tracks Biotherapeutics

    Polycystic Ovary Syndrome

    phase 3 small molecule completed

    1 trial

  10. mitoxantrone liposome, Ara-Cytarabine and azacitidine

    First Tracks Biotherapeutics

    Acute Myeloid Leukaemia

    phase 3 small molecule active

    1 trial

  11. mycophenolate mofetil 2 g per day

    First Tracks Biotherapeutics

    Lymphocytic Myocarditis (Disorder)

    phase 3 small molecule completed

    1 trial

  12. nab-paclitaxel combined with carboplatin

    First Tracks Biotherapeutics

    Epithelial Ovarian Carcinoma Stage III

    phase 3 small molecule active

    1 trial

  13. paclitaxel/anthracycline

    First Tracks Biotherapeutics

    Primary Breast Cancer

    phase 3 small molecule active

    1 trial

  14. patients undergo cVATS segmentectomy

    First Tracks Biotherapeutics

    Non-small Cell Lung Cancer Stage I

    phase 3 other active

    1 trial

  15. probiotics, antibiotics or antidepressants

    First Tracks Biotherapeutics

    Irritable Bowel Syndrome

    phase 3 small molecule active

    1 trial

  16. recombinant human erythropoietin

    First Tracks Biotherapeutics

    Lymphoma

    phase 3 small molecule active

    1 trial

  17. recombinant human thrombopoietin

    First Tracks Biotherapeutics

    Immune Thrombocytopenia

    phase 3 small molecule active

    1 trial

  18. rhTPO

    First Tracks Biotherapeutics

    Immune Thrombocytopenia

    phase 3 small molecule active

    1 trial

  19. the Shouhui Tongbian Capsule

    First Tracks Biotherapeutics

    OIC

    phase 3 small molecule active

    1 trial

  20. ticagrelor

    First Tracks Biotherapeutics

    Coronary Artery Disease

    phase 3 small molecule active

    1 trial

  21. venetoclax

    First Tracks Biotherapeutics

    Acute Promyelocytic Leukemia

    phase 3 small molecule active

    1 trial

  22. "Endostar"

    First Tracks Biotherapeutics

    Esophageal

    phase 2 small molecule terminated

    1 trial

  23. 0.9% sodium chloride

    First Tracks Biotherapeutics

    Kidney Disease, Chronic

    phase 2 small molecule active

    1 trial

  24. 177Lu-DOTA-EB-FAPI radionuclide therapy

    First Tracks Biotherapeutics

    Refractory Solid Tumor

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources